Acquired factor V inhibitor in a patient with a mechanical aortic valve under warfarin therapy

7Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

Abstract

An 84-year-old woman under warfarin therapy, who had undergone mechanical valve replacement 29 months previously, developed coagulation abnormalities after antibiotic treatment for pyelonephritis. Laboratory findings included PT at 47.6 sec, activated thromboplastin time (APTT) at 147 sec, factor V (FV) activity of 4% and FV inhibitor of 8 BU. Although overt bleeding was not observed, administration of prednisolone was started. Her coagulation abnormalities were rapidly normalized. It was later determined that the patient had received bovine thrombin at surgery. The presence of a FV inhibitor should be considered in the differential diagnosis in patients demonstrating an unexpected prolongation of PT under warfarin therapy following surgery. © 2010 The Japanese Society of Internal Medicine.

Cite

CITATION STYLE

APA

Nozu, T., Mita, H., & Okumura, T. (2010). Acquired factor V inhibitor in a patient with a mechanical aortic valve under warfarin therapy. Internal Medicine, 49(20), 2229–2233. https://doi.org/10.2169/internalmedicine.49.4042

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free